1.
|
Phase: Phase IV Type: Treatment Status: Active Age: Any age Sponsor: Pharmaceutical / Industry Protocol IDs: PRT10T, NCT01264822
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: HELYX Study, NCT00154440
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: 0707009285, RV-MM-PI-238, NCT00538733
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1004011012, PO-MM-PI-0023, NCT01159574
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CLEAR, NCT01279252
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HD-K, NCT01516606
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 1108011903, NCT01559935
|
|
8.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: No age specified Sponsor: Other Protocol IDs: T3206, NCT00327132
|
|
9.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: IMI2010-1, 1000-05-310123, NCT01137942
|
|
10.
|
Phase: No phase specified Type: Supportive care Status: Active Age: Not specified Sponsor: Pharmaceutical / Industry Protocol IDs: D961HC00011, NCT01435525
|